Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
4
Citations
NaN
KQI